Players of 'hypoxia orchestra' - what is the role of FMISO?

Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1679-1681. doi: 10.1007/s00259-017-3754-9. Epub 2017 Jun 20.

Authors

Takuya Toyonaga¹, Kenji Hirata², Tohru Shiga¹, Tamaki Nagara^{1

3}

Affiliations

¹ Department of Nuclear Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan, 060-8638, Japan.
² Department of Nuclear Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan, 060-8638, Japan. khirata@med.hokudai.ac.jp.
³ Department of Radiology, Kyoto Prefectural University of Medicine, Kyoto, Japan.

PMID: 28634683
DOI: 10.1007/s00259-017-3754-9

No abstract available

Publication types

Editorial

MeSH terms

Humans
Misonidazole / analogs & derivatives*
Misonidazole / pharmacokinetics
Neoplasms / diagnostic imaging*
Neoplasms / metabolism*
Oxygen / metabolism*
Positron-Emission Tomography / methods*
Radiopharmaceuticals / pharmacokinetics
Tumor Hypoxia*

Substances

Radiopharmaceuticals
fluoromisonidazole
Misonidazole
Oxygen